Compare GSK plc (GSK) vs Materials Select Sector SPDR Fund (XLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Materials Select Sector SPDR Fund — how do they compare? GSK plc trades at $52.66 (market cap $101.34B), while Materials Select Sector SPDR Fund trades at $50.72. The key difference: GSK plc pays a 3.49% dividend while Materials Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| GSK | XLB | |
|---|---|---|
Market Cap | $101.34B | — |
Sector | Health | — |
52-Week High | $61.18 | $53.62 |
52-Week Low | $36.20 | $42.23 |
Enterprise Value | $121.95B | — |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
XLB trades at $50.69, up 0.1% with a bearish technical signal from moving averages and neutral oscillators. The materials sector ETF faces mixed sentiment, with Seeking Alpha rating it 'Hold' due to limited upside after recent gains. Support sits at $50, resistance at $51. A dividend of $0.19 is scheduled for June 2026, but key financial ratios like P/E and ROE are unavailable in the current data.
Outlook is cautious; geopolitical risks and inflation may pressure materials stocks, while infrastructure trends offer support. Analyst consensus leans neutral, with earnings growth potential offset by high valuations. Risks include sector concentration and macroeconomic shifts, requiring careful monitoring for entry points.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →
